Stay updated on IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial
Sign up to get notified when there's something new on the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page.

Latest updates to the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page
- Check2 days agoChange DetectedA site-wide notice about a lapse in government funding and current operating status was added, directing users to official status sources. The revision tag was updated to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.7%

- Check9 days agoChange DetectedThe history page now includes a glossary toggle and color-coded highlights (green for additions, red for deletions) with a new Revision: v3.4.0 tag. The previous Revision: v3.3.4 entry and the No FEAR Act data entry were removed.SummaryDifference1.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedVersion v3.3.4 appears in the page history, replacing v3.3.3. This is a minor site revision and does not modify study data or user-facing content.SummaryDifference0.1%

- Check45 days agoChange DetectedAdded Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer.SummaryDifference0.2%

- Check74 days agoChange DetectedRecord history shows a new revision v3.3.2 was added and revision v3.2.0 was removed from the NCT02676869 record, indicating a minor maintenance/version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check81 days agoChange DetectedThe government operating status notice about funding has been removed. All other study history content remains unchanged.SummaryDifference0.7%

Stay in the know with updates to IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page.